acetylcarnitine has been researched along with sb 239063 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, M; Davies, CH; Fellows, AD; Gibbs, KL; Greensmith, L; Kalmar, B; Rhymes, ER; Schiavo, G; Whiting, P | 1 |
1 other study(ies) available for acetylcarnitine and sb 239063
Article | Year |
---|---|
Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS.
Topics: Acetylcarnitine; Amyotrophic Lateral Sclerosis; Animals; Axonal Transport; Disease Models, Animal; Enzyme Activation; Hindlimb; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice, Inbred C57BL; Mice, Transgenic; Motor Neurons; Muscles; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyrimidines; Quinazolinones; Receptors, Nerve Growth Factor; Superoxide Dismutase; Tetanus Toxin | 2018 |